WO2001015547A3 - Wirkstoffpräparat für tierärztliche applikation und verfahren zu seiner herstellung - Google Patents

Wirkstoffpräparat für tierärztliche applikation und verfahren zu seiner herstellung Download PDF

Info

Publication number
WO2001015547A3
WO2001015547A3 PCT/DE2000/002525 DE0002525W WO0115547A3 WO 2001015547 A3 WO2001015547 A3 WO 2001015547A3 DE 0002525 W DE0002525 W DE 0002525W WO 0115547 A3 WO0115547 A3 WO 0115547A3
Authority
WO
WIPO (PCT)
Prior art keywords
active agent
veterinary use
production
agent preparation
active
Prior art date
Application number
PCT/DE2000/002525
Other languages
English (en)
French (fr)
Other versions
WO2001015547A2 (de
Inventor
Hartmut Klocke
Original Assignee
Hartmut Klocke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hartmut Klocke filed Critical Hartmut Klocke
Priority to AU72688/00A priority Critical patent/AU7268800A/en
Publication of WO2001015547A2 publication Critical patent/WO2001015547A2/de
Publication of WO2001015547A3 publication Critical patent/WO2001015547A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Ein Verfahren zur Herstellung eines Wirkstoffpräparates für tierärztliche Applikation weist mindestens einen ersten Wirkstoff geringer Akzeptanz durch das Tier auf, der als Bestandteil in Aktivkerne eingebunden wird. Die Aktivkerne sind von einer Umhüllung zumindest so weit umschlossen, dass der erste Wirkstoff sensorisch vom Tier nicht mehr medikationshindernd wahrnehmbar ist. Dadurch ist sichergestellt, dass die Medikationswirkung eines Wirkstoffs auch dann sichergestellt ist, wenn dieser beispielsweise einen unangenehmen Geschmack aufweist.
PCT/DE2000/002525 1999-08-28 2000-08-01 Wirkstoffpräparat für tierärztliche applikation und verfahren zu seiner herstellung WO2001015547A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU72688/00A AU7268800A (en) 1999-08-28 2000-08-01 Active agent preparation for veterinary use and method for the production thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19941024.0 1999-08-28
DE1999141024 DE19941024A1 (de) 1999-08-28 1999-08-28 Wirkstoffpräparat für tierärztliche Applikation und Verfahren zu seiner Herstellung

Publications (2)

Publication Number Publication Date
WO2001015547A2 WO2001015547A2 (de) 2001-03-08
WO2001015547A3 true WO2001015547A3 (de) 2001-08-02

Family

ID=7920027

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2000/002525 WO2001015547A2 (de) 1999-08-28 2000-08-01 Wirkstoffpräparat für tierärztliche applikation und verfahren zu seiner herstellung

Country Status (3)

Country Link
AU (1) AU7268800A (de)
DE (1) DE19941024A1 (de)
WO (1) WO2001015547A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2403407B (en) * 2003-07-03 2006-12-13 Michael Hilary Burke Palatable oral anthelmintic composition
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
JP6290081B2 (ja) 2011-09-15 2018-03-07 フリウルケム、ソシエタ、ペル、アチオニＦｒｉｕｌｃｈｅｍ Ｓｐａ 動物への経口投与用組成物、その製造方法およびその使用
WO2014033230A1 (fr) 2012-08-31 2014-03-06 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
CN103933045A (zh) * 2014-05-14 2014-07-23 深圳市红瑞生物科技有限公司 驱虫药物及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283400A (en) * 1978-09-25 1981-08-11 Bayer Aktiengesellschaft Medicated animal feed based on liver meal
EP0293070A1 (de) * 1987-04-01 1988-11-30 Strathclyde Chemical Co. Ltd. Orales Mittel zur Verabreichung einer Wirksubstanz an ein Tier
EP0320320A2 (de) * 1987-12-08 1989-06-14 So.Ge.Val S.A. Tablette für Haustiere
EP0717993A2 (de) * 1994-11-28 1996-06-26 Virbac S.A. Antihelmintische Zusammensetzungen für Pferde

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283400A (en) * 1978-09-25 1981-08-11 Bayer Aktiengesellschaft Medicated animal feed based on liver meal
EP0293070A1 (de) * 1987-04-01 1988-11-30 Strathclyde Chemical Co. Ltd. Orales Mittel zur Verabreichung einer Wirksubstanz an ein Tier
EP0320320A2 (de) * 1987-12-08 1989-06-14 So.Ge.Val S.A. Tablette für Haustiere
EP0717993A2 (de) * 1994-11-28 1996-06-26 Virbac S.A. Antihelmintische Zusammensetzungen für Pferde

Also Published As

Publication number Publication date
WO2001015547A2 (de) 2001-03-08
AU7268800A (en) 2001-03-26
DE19941024A1 (de) 2001-03-01

Similar Documents

Publication Publication Date Title
WO2004045537A3 (en) Edible film for relief of cough or symptoms associated with pharyngitis
HK1047575A1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
ATE421318T1 (de) Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
ZA200301813B (en) Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them.
DE60020716D1 (de) Filmbildende zusammensetzungen aus pullulan
AU2001278771A1 (en) Carboxylic acid derivatives, process for producing the same and drugs containingthe same as the active ingredient
GB9903216D0 (en) Preservative compounds,compositions and methods of making and using the same
HUP9600116A3 (en) Fungicidal composition containing benzophenone, process for preparation of the active ingredients and method for the control of fungi.
HK1047584A1 (en) Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process.
WO2002036106A3 (de) Neue arzneimittelkompositionen auf der basis von anticholingergika und corticosteroiden
AU2002231095A1 (en) Method and composition for the treatment of diabetic neuropathy
DE60133028D1 (de) Mikrogranulat auf wirkstoffbasis und verfahren zu seiner herstellung
AP2004003045A0 (en) Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same.
ZA200003768B (en) Methods and compositions for treating diseases and conditions of the eye.
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
RS50148B (sr) Upotreba docetaksela za lečenje hepatoćelijskog karcinoma
AU2001276698A1 (en) Pyrazole derivatives, pest controllers containing the same as the active ingredient and process for their production
WO2001015547A3 (de) Wirkstoffpräparat für tierärztliche applikation und verfahren zu seiner herstellung
WO2002049607A3 (en) Flavoured oral drug delivery system
DE60002089D1 (de) Niedrig dosierte tabletten, und verfahren zur herstellung
WO2002053149A3 (de) Arzneimittel enthaltend ein polyamin als wirksubstanz
WO2002058532A3 (en) Method for identifying ligands to lxr-receptor that stimulates pre-adipocyte differentiation and formulations thereof
AU2000279747A1 (en) Emulsion of perfluororganic compounds for medical purposes, method for producingsaid emulsion and methods for curing and preventing diseases with the aid of the emulsion
AU2002237578A1 (en) Functional agent for decomposing nicotine and method of preparing the same
NO20031108L (no) Farmasöytisk preparat for behandling av hodepine, og fremgangsmåte for fremstilling av preparatet

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP